59,842 Shares in Sotera Health Company $SHC Acquired by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC bought a new stake in shares of Sotera Health Company (NASDAQ:SHC) in the fourth quarter, Holdings Channel.com reports. The fund bought 59,842 shares of the company’s stock, valued at approximately $1,125,000.

Several other hedge funds have also recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC boosted its stake in shares of Sotera Health by 831.4% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock valued at $37,000 after purchasing an additional 2,935 shares during the last quarter. Versant Capital Management Inc lifted its holdings in Sotera Health by 117.6% in the third quarter. Versant Capital Management Inc now owns 2,535 shares of the company’s stock valued at $40,000 after buying an additional 1,370 shares during the period. Fairway Wealth LLC bought a new stake in Sotera Health during the third quarter valued at $57,000. CWM LLC boosted its position in Sotera Health by 194.6% during the third quarter. CWM LLC now owns 5,191 shares of the company’s stock valued at $82,000 after acquiring an additional 3,429 shares during the last quarter. Finally, GAMMA Investing LLC grew its holdings in Sotera Health by 31.1% during the 4th quarter. GAMMA Investing LLC now owns 4,892 shares of the company’s stock worth $86,000 after acquiring an additional 1,161 shares during the period. Institutional investors own 91.03% of the company’s stock.

Sotera Health Price Performance

Shares of NASDAQ:SHC opened at $14.96 on Monday. The business’s 50 day moving average is $15.85 and its 200 day moving average is $16.53. Sotera Health Company has a 12-month low of $9.53 and a 12-month high of $19.85. The stock has a market cap of $4.25 billion, a price-to-earnings ratio of 55.41 and a beta of 1.88. The company has a quick ratio of 2.24, a current ratio of 2.46 and a debt-to-equity ratio of 3.66.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings data on Tuesday, February 24th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.02. The business had revenue of $303.44 million for the quarter, compared to analysts’ expectations of $300.68 million. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.The business’s revenue was up 4.6% on a year-over-year basis. During the same period last year, the business earned $0.21 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. On average, sell-side analysts forecast that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction that occurred on Friday, March 6th. The shares were sold at an average price of $15.27, for a total transaction of $152,700,000.00. Following the transaction, the director owned 12,735,301 shares of the company’s stock, valued at $194,468,046.27. This trade represents a 43.98% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 47.55% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. William Blair began coverage on Sotera Health in a research report on Thursday, December 18th. They set an “outperform” rating on the stock. Wells Fargo & Company cut Sotera Health to an “overweight” rating in a report on Thursday, January 8th. Piper Sandler upgraded shares of Sotera Health from a “neutral” rating to an “overweight” rating and boosted their target price for the company from $17.00 to $24.00 in a research report on Friday, January 9th. Citigroup raised their price target on shares of Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, February 24th. Finally, Zacks Research downgraded shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 30th. Eight analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $20.43.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.